ATE520987T1 - Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum - Google Patents

Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum

Info

Publication number
ATE520987T1
ATE520987T1 AT03750379T AT03750379T ATE520987T1 AT E520987 T1 ATE520987 T1 AT E520987T1 AT 03750379 T AT03750379 T AT 03750379T AT 03750379 T AT03750379 T AT 03750379T AT E520987 T1 ATE520987 T1 AT E520987T1
Authority
AT
Austria
Prior art keywords
individual
cancer
screening
detecting
monitoring
Prior art date
Application number
AT03750379T
Other languages
English (en)
Inventor
Lasse Hessel
Jesper Malling
Nils Bruenner
Mads Holten-Andersen
Hans Nielsen
Original Assignee
Hvidovre Hospital
Rigshospitalet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hvidovre Hospital, Rigshospitalet filed Critical Hvidovre Hospital
Application granted granted Critical
Publication of ATE520987T1 publication Critical patent/ATE520987T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03750379T 2002-09-26 2003-09-26 Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum ATE520987T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200201430 2002-09-26
PCT/DK2003/000634 WO2004029627A1 (en) 2002-09-26 2003-09-26 A method for detecting, screening and/or monitoring a cancer in an individual

Publications (1)

Publication Number Publication Date
ATE520987T1 true ATE520987T1 (de) 2011-09-15

Family

ID=32039055

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03750379T ATE520987T1 (de) 2002-09-26 2003-09-26 Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum

Country Status (9)

Country Link
US (1) US20060014224A1 (de)
EP (1) EP1561113B1 (de)
JP (1) JP2006500574A (de)
CN (1) CN1685235A (de)
AT (1) ATE520987T1 (de)
AU (1) AU2003269837B9 (de)
CA (1) CA2500232A1 (de)
NZ (1) NZ539345A (de)
WO (1) WO2004029627A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108983B1 (en) * 1999-04-09 2006-09-19 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
US7374886B2 (en) * 1999-04-09 2008-05-20 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
US20060154245A1 (en) * 1999-04-09 2006-07-13 Rigshospitalet Method for detecting, screening and/or montoring a cancer in individual
US20080019910A1 (en) * 2004-03-30 2008-01-24 Romer Maria U Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease Inhibitors
EP1945816B1 (de) * 2005-10-21 2011-07-27 GeneNews Inc. Verfahren und vorrichtung zur korrelierung der ebenen von biomarker-produkten mit erkrankungen
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
KR20120087885A (ko) * 2007-06-29 2012-08-07 안국약품 주식회사 난소암의 예측 마커
JP2010054305A (ja) * 2008-08-27 2010-03-11 Tohoku Denshi Sangyo Kk 癌罹病の検定に使用するデータの収集方法
MX2011004174A (es) * 2008-10-21 2011-09-27 Astute Medical Inc Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal.
CN102326080B (zh) * 2009-02-20 2015-08-05 加利福尼亚大学董事会 A+生物标志物的试验
JP6443937B2 (ja) * 2013-10-28 2018-12-26 株式会社サリバテック 膵癌用唾液バイオマーカー、及び、これを用いた膵癌患者を健常者から識別する方法
CN104004840B (zh) * 2014-05-26 2016-06-08 高新 用于早期筛查与诊断前列腺癌的试剂盒
WO2023225723A1 (en) * 2022-05-27 2023-11-30 Griffith University Biomarkers of fibrosis and uses therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
JPH08136548A (ja) 1994-11-11 1996-05-31 Morinaga & Co Ltd 泌尿器癌の診断法
JPH11139947A (ja) * 1997-11-11 1999-05-25 Sunstar Inc マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物
US7108983B1 (en) * 1999-04-09 2006-09-19 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
CA2425761C (en) * 2000-10-13 2005-11-15 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
WO2003087830A2 (en) 2002-04-08 2003-10-23 Rigshospitalet Timp-1 as a postoperative marker for recurrent cancer

Also Published As

Publication number Publication date
CN1685235A (zh) 2005-10-19
US20060014224A1 (en) 2006-01-19
EP1561113A1 (de) 2005-08-10
AU2003269837B9 (en) 2009-07-30
CA2500232A1 (en) 2004-04-08
AU2003269837B2 (en) 2009-03-26
WO2004029627A1 (en) 2004-04-08
NZ539345A (en) 2008-04-30
EP1561113B1 (de) 2011-08-17
AU2003269837A1 (en) 2004-04-19
JP2006500574A (ja) 2006-01-05

Similar Documents

Publication Publication Date Title
ATE520987T1 (de) Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
DE60310286D1 (de) Vorrichtung und Verfahren zur nicht-invasiven Bestimmung der Konzentrationen von biologischen Flüssigkeiten mittels photoakustischer Spektroskopie
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
Alshihri et al. Dental age assessment of Western Saudi children and adolescents
DE60207979D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
DE602004027739D1 (de) Vorrichtung und verfahren zum sammeln von biologischen fluidproben und zur behandlung von ausgewählten komponenten
DE60325617D1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
ATE540676T1 (de) Egfr-inhibitoren zur behandlung und diagnose von metastasierendem prostatakrebs
ATE468811T1 (de) Verfahren und system zur überwachung von beatmungen
DE602006007814D1 (de) Vorrichtung und Verfahren zum Messen der Durchgangszeit des Sauerstoffes im Blut
JP2010256190A5 (de)
ATE282208T1 (de) Verfahren und vorrichtung zum vorhersagen von haemostatischer funktionsstörung in patientenproben
EP1550462A4 (de) MITTEL ZUR BEHANDLUNG ODER PRûVENTION VON NIERENERKRANKUNGEN UND VERFAHREN ZUR DIAGNOSE VON NIERENERKRANKUNGEN
EP1794318A4 (de) Arzneistoff-screening und molekularer diagnosetest zum frühen nachweis von kolorektalkarzinom: reagentien, verfahren und kits dafür
ATE557087T1 (de) Verfahren und kit zum nachweis von sklerose verursachenden proliferativen erkrankungen und/oder heilmittel gegen sklerose verursachende proliferative erkrankungen sowie verfahren und kit zur identifizierung einer bei der vorbeugung und/oder behandlung von sklerose verursachenden proliferativen erkrankungen wirksamen substanz
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
DE502004006374D1 (de) Verfahren und Vorrichtung zur quantitativen Analyse von Motorgeräuschen
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
DE50101715D1 (de) Verfahren zum nachweis von alpha-oxoaldehyden in vollblut, blutplasma und/oder serum eines patienten
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
ATE483982T1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
EP1635694A4 (de) Verfahren zur diagnose, prognose und behandlung von brustkrebs
DE602005026665D1 (de) Angereicherter antikörper zur detektion von mikrobakterieller infektion, verfahren zur anwendung und diagnosetest damit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties